| pubmed-article:19464421 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19464421 | lifeskim:mentions | umls-concept:C0155626 | lld:lifeskim |
| pubmed-article:19464421 | lifeskim:mentions | umls-concept:C0961485 | lld:lifeskim |
| pubmed-article:19464421 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:19464421 | lifeskim:mentions | umls-concept:C0600520 | lld:lifeskim |
| pubmed-article:19464421 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:19464421 | pubmed:dateCreated | 2009-5-25 | lld:pubmed |
| pubmed-article:19464421 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19464421 | pubmed:abstractText | Aldosterone antagonism reduces cardiovascular morbidity and mortality in patients with left ventricular (LV) systolic dysfunction and heart failure or diabetes after acute myocardial infarction (AMI). The mechanism of this effect is unclear. We performed a contrast-enhanced cardiac magnetic resonance study to assess the effects of eplerenone on LV remodeling after AMI. | lld:pubmed |
| pubmed-article:19464421 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19464421 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19464421 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:19464421 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19464421 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19464421 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19464421 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19464421 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19464421 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19464421 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19464421 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:19464421 | pubmed:issn | 1097-6744 | lld:pubmed |
| pubmed-article:19464421 | pubmed:author | pubmed-author:SquireIain... | lld:pubmed |
| pubmed-article:19464421 | pubmed:author | pubmed-author:NgLeong LLL | lld:pubmed |
| pubmed-article:19464421 | pubmed:author | pubmed-author:WagnerGalen... | lld:pubmed |
| pubmed-article:19464421 | pubmed:author | pubmed-author:McMurrayJohn... | lld:pubmed |
| pubmed-article:19464421 | pubmed:author | pubmed-author:FordIanI | lld:pubmed |
| pubmed-article:19464421 | pubmed:author | pubmed-author:DargieHenry... | lld:pubmed |
| pubmed-article:19464421 | pubmed:author | pubmed-author:MarkPatrick... | lld:pubmed |
| pubmed-article:19464421 | pubmed:author | pubmed-author:PetrieColin... | lld:pubmed |
| pubmed-article:19464421 | pubmed:author | pubmed-author:SteedmanTrace... | lld:pubmed |
| pubmed-article:19464421 | pubmed:author | pubmed-author:WeirRobin A... | lld:pubmed |
| pubmed-article:19464421 | pubmed:author | pubmed-author:ClementsSuzan... | lld:pubmed |
| pubmed-article:19464421 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19464421 | pubmed:volume | 157 | lld:pubmed |
| pubmed-article:19464421 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19464421 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19464421 | pubmed:pagination | 1088-96 | lld:pubmed |
| pubmed-article:19464421 | pubmed:meshHeading | pubmed-meshheading:19464421... | lld:pubmed |
| pubmed-article:19464421 | pubmed:meshHeading | pubmed-meshheading:19464421... | lld:pubmed |
| pubmed-article:19464421 | pubmed:meshHeading | pubmed-meshheading:19464421... | lld:pubmed |
| pubmed-article:19464421 | pubmed:meshHeading | pubmed-meshheading:19464421... | lld:pubmed |
| pubmed-article:19464421 | pubmed:meshHeading | pubmed-meshheading:19464421... | lld:pubmed |
| pubmed-article:19464421 | pubmed:meshHeading | pubmed-meshheading:19464421... | lld:pubmed |
| pubmed-article:19464421 | pubmed:meshHeading | pubmed-meshheading:19464421... | lld:pubmed |
| pubmed-article:19464421 | pubmed:meshHeading | pubmed-meshheading:19464421... | lld:pubmed |
| pubmed-article:19464421 | pubmed:meshHeading | pubmed-meshheading:19464421... | lld:pubmed |
| pubmed-article:19464421 | pubmed:meshHeading | pubmed-meshheading:19464421... | lld:pubmed |
| pubmed-article:19464421 | pubmed:meshHeading | pubmed-meshheading:19464421... | lld:pubmed |
| pubmed-article:19464421 | pubmed:meshHeading | pubmed-meshheading:19464421... | lld:pubmed |
| pubmed-article:19464421 | pubmed:meshHeading | pubmed-meshheading:19464421... | lld:pubmed |
| pubmed-article:19464421 | pubmed:meshHeading | pubmed-meshheading:19464421... | lld:pubmed |
| pubmed-article:19464421 | pubmed:meshHeading | pubmed-meshheading:19464421... | lld:pubmed |
| pubmed-article:19464421 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19464421 | pubmed:articleTitle | Left ventricular remodeling after acute myocardial infarction: does eplerenone have an effect? | lld:pubmed |
| pubmed-article:19464421 | pubmed:affiliation | Cardiology Department, Western Infirmary, Glasgow, Scotland, United Kingdom. robinweir75@hotmail.com | lld:pubmed |
| pubmed-article:19464421 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19464421 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
